Can the product be customized?

Yes, full customization is available, including customization from designs and samples.

What are the payment terms?

Payment terms include T/T, LC, and D/P.

What is the lead time for delivery?

The average lead time is one month for both peak and off-peak seasons.

Enoxaparin Sodium Injection, GMP Medicine

Name: Enoxaparin Sodium Injection, GMP Medicine
Brand: Anhui Medipharm Co., Ltd.
SKU: 1910557241

Anhui, ChinaAnhui Medipharm Co., Ltd.

US$2.20-3.70

50,000 vials

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Inject

Model NO.

AMC14084

Suitable for

Elderly, Children, Adult

State

Liquid

Shape

Injection

Type

Biological Products

Pharmaceutical Technology

Chemical Synthesis

Transport Package

2's/Box 200boxes/CTN

Specification

20mg/0.2ml; 40mg/0.4ml; 60mg/0.6ml; 80mg/0.8ml

Trademark

Medipharm, OEM

Origin

China

HS Code

3004909099

Production Capacity

500000 Boxes/Month

Key features

GMP Certified Production: Manufactured under strict GMP standards ensuring high quality and safety.

Multiple Strength Options: Available in 2000, 4000, 6000, and 8000 Axa IU strengths for flexible dosing.

Comprehensive Indications: Used for VTE prophylaxis, DVT treatment, unstable angina, and hemodialysis.

Long Shelf Life: Product maintains stability and efficacy for 24 months from manufacture date.

Convenient Packaging: Supplied in pre-filled syringes with 2 units per pack for easy administration.

Full Customization Available: Offers full customization including designs and samples for specific needs.

ISO Certified Management: Company holds ISO9001, ISO45001, and ISO14001 certifications for quality.

Global Market Reach: Exports to South America, Southeast Asia, Middle East, Africa, and South Asia.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersManagement Certification

Anhui Medipharm Co., Ltd.

Anhui, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.00h

AI-Powered supplier vetting

SummaryAnhui Medipharm Co., Ltd. is a China-based trading company established in 2010 with 32 employees and a broad healthcare-related product scope. It has overseas agents or branches, participated in the 136th Canton Fair, and exports 90% of total sales, but no overseas showroom is reported. Service procedures, corrective and preventive action procedures, and complaint-handling procedures are documented and supported by records. The supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications, although it lacks a factory environmental impact assessment report. Innovation and customization are supported by recent new products, ODM services, and multiple customization methods. Production capability is not demonstrated because the supplier is identified as a trading company and no manufacturing capacity is provided. Financial information only identifies reporting years, without substantive performance data. No specific customer cases are provided.

Supplier typeThe supplier is identified as a trading company or trade company, organized as a limited company in Hefei, Anhui, China, with 32 employees. Its listed product scope covers medicines, veterinary drugs, nutritional and medical products, additives, APIs, and related categories, indicating broad trading coverage rather than confirmed in-house manufacturing.

CertificationsThe supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications. However, it also reports no factory environmental impact assessment report; this does not negate the stated certifications but indicates incomplete environmental documentation for factory-related assessment.

After-Sales capabilityThe supplier has overseas agents or branches, has participated in the 136th Canton Fair, and serves listed markets including Papua New Guinea and Cameroon. Written procedures and records exist for service assessment, corrective and preventive actions, and customer complaints, while stated peak- and off-season lead times are both one month.

R&D capabilityThe supplier reports launching new products during the past year and provides ODM services, supporting active product development. It does not provide an SDK and does not offer OEM services for well-known brands, so the evidence supports product innovation but not software-development or major-brand OEM capability.

Customization capabilityThe supplier reports customization from designs, customization from samples, and full customization, as well as ODM service availability. These statements explicitly support a broad customization offering, although the evidence does not quantify capacity or specify production ownership.